Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Analysis of Treatment With Palbociclib in Patients With Locally Advanced and / or Metastatic RH + / HER 2- Breast Cancer in the First Line of Treatment Within Routine Clinical Practice.

NCT04874025 is registered in ClinicalTrials.gov with Hospital San Carlos, Madrid as lead sponsor.

NCT NCT04874025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Analysis of Treatment With Palbociclib in Patients With Locally Advanced and / or Metastatic RH + / HER 2- Breast Cancer in the First Line of Treatment Within Routine Clinical Practice.
Lead sponsor
Hospital San Carlos, Madrid
Phase
Observational
Overall status
Completed
Start date
July 31, 2021
Completion date
June 8, 2022
Enrollment
815 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer